The Clinical Impact of Vascular Endothelial Growth Factor/Receptor (VEGF/R) Inhibitors on Voice
Background. Vascular endothelial growth factor/receptor (VEGF/R) inhibitors are used in chemotherapy protocols to limit tumor angiogenesis. Recent evidence shows they are associated with hoarseness, but their impact on vocal cord function has not been fully identified. Objectives. To describe the pr...
Saved in:
Main Authors: | Christina Hui Lee Ng, Edward J. Damrose |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Case Reports in Otolaryngology |
Online Access: | http://dx.doi.org/10.1155/2023/1902876 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vascular Endothelial Growth Factor (VEGF) Family and the Immune System: Activators or Inhibitors?
by: Cristina Maria Failla, et al.
Published: (2024-12-01) -
Exceptional Response of Metastatic Chromophobe Renal Cell Carcinoma to Vascular Endothelial Growth Factor (VEGF) Inhibitors: Should Increased VEGF-C Expression Be Used to Guide Treatment?
by: Jacob W. Bruinius, et al.
Published: (2019-01-01) -
Automated and Reproducible Detection of Vascular Endothelial Growth Factor (VEGF) in Renal Tissue Sections
by: Nayana Damiani Macedo, et al.
Published: (2019-01-01) -
Association of vascular endothelial growth factor B (VEGFВ) gene polymorphisms with intracranial aneurysms
by: R. I. Sultanova, et al.
Published: (2019-01-01) -
Genistein Ameliorated Vascular Endothelial Growth Factor-A (VEGF-A) and Estrogen Receptor-Alpha (ER-α) in Endometriosis Mice Model, In Vivo and In Silico
by: Sutrisno Sutrisno, et al.
Published: (2024-01-01)